Mustang Bio (MBIO) Accounts Payables (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Accounts Payables of $3.3 million for Q1 2026, down 59.93% year-over-year from $8.3 million in Q1 2025, and down 4.81% quarter-over-quarter from $3.5 million in Q4 2025.
Mustang Bio (MBIO) Accounts Payables (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Accounts Payables for 11 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 59.93% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 59.93% YoY), while the FY2025 annual figure was $3.5 million, down 63.0% from the prior year.
- Accounts Payables slipped to $3.3 million in Q1 2026 per MBIO's latest filing, from $3.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $15.0 million in Q1 2024 and bottomed at $3.3 million in Q1 2026.
- Historically, Accounts Payables has averaged $9.5 million across 5 years, with a median of $9.6 million in 2022.
- Annual changes were most pronounced in 2024 — Accounts Payables soared 134.48% — and 2025, when it tumbled 63.0%.
- Mustang Bio's Accounts Payables stood at $13.7 million in 2022, then climbed by 2.08% to $14.0 million in 2023, then sank by 32.33% to $9.5 million in 2024, then sank by 63.0% to $3.5 million in 2025, then fell by 4.81% to $3.3 million in 2026.
- Business Quant data shows MBIO's Accounts Payables at $3.3 million in Q1 2026, $3.5 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Mustang Bio | 3.82 Mn | 3.82 Mn | - | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.38 Mn |
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 4.99 Mn |
| Jun 30, 2025 | 5.65 Mn |
| Mar 31, 2025 | 8.34 Mn |
| Dec 31, 2024 | 9.49 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 13.19 Mn |
| Mar 31, 2024 | 15.01 Mn |
| Dec 31, 2023 | 14.02 Mn |
| Sep 30, 2023 | 12.71 Mn |
| Jun 30, 2023 | 11.68 Mn |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | 13.73 Mn |
| Sep 30, 2022 | 12.81 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 9.74 Mn |
| Sep 30, 2021 | 9.83 Mn |